MeMed
Haifa, Israel · Founded 2009 · $107.1M raised
- Headquarters
- Haifa
- Employees
- 51–200
- Founded
- 2009
- Business Model
- B2B
- Website
- me-med.com
- Total Funding
- $107.1M
- Last Round
- $14.1M Growth EquityMay 2026
- Rounds
- 2
About
MeMed is an Israeli medtech company developing rapid host-immune response diagnostics to distinguish bacterial from viral infections at point of care.
Summary
MeMed is a Biotech company based in Haifa, Israel, founded in 2009. It has raised $107.1M in total across 2 rounds, most recently a $14.1M Growth Equity round in May 2026. Investors include DGF Investimentos, BridgeOne and DNA Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...